Aft Pharmaceuticals Limited

Pediatric Pain Management

AFT Pharmaceuticals Limited supports research into analgesic therapies designed specifically for younger patient populations. The company’s investigational work focuses on understanding how pain relief medications perform in children and adolescents, examining both the way these treatments are processed by developing bodies and their safety profiles in pediatric patients.

  • Intravenous analgesic formulations for acute pain
  • Pharmacokinetic studies in children and adolescents
  • Safety evaluation of combination analgesic products

The research emphasizes the importance of establishing appropriate therapeutic approaches for acute pain conditions in patients ranging from early childhood through adolescence, addressing a critical need for age-appropriate pain management solutions.

Dermatological Vascular Conditions

AFT Pharmaceuticals Limited investigates therapeutic interventions for vascular birthmarks and related dermatological conditions. The company’s research portfolio includes studies examining topical treatments intended to enhance outcomes when used alongside established laser-based therapies for port wine stains.

  • Topical immunomodulatory agents for vascular malformations
  • Combination approaches with pulsed dye laser therapy
  • Dose-ranging studies for dermatological applications

This research area reflects an interest in improving cosmetic and therapeutic outcomes for patients with congenital vascular lesions, exploring how topical formulations can complement existing treatment modalities to enhance the appearance of affected skin.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Sirolimus Cream for Patients with Port Wine Stains

    Recruiting

    2 1 1
    Investigated drugs:
    Spain
  • A study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Hungary